InvestorsHub Logo
Followers 832
Posts 119954
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 401

Wednesday, 03/08/2017 12:34:34 PM

Wednesday, March 08, 2017 12:34:34 PM

Post# of 1163
BMY hires MGH* doctor as CSO:

http://investor.bms.com/investors/news-and-events/press-releases/press-release-details/2017/Bristol-Myers-Squibb-Appoints-Dr-Thomas-J-Lynch-Jr-Executive-Vice-President-and-Chief-Scientific-Officer/default.aspx

Bristol-Myers Squibb Company today announced that it has appointed Dr. Thomas J. Lynch, Jr., 56, executive vice president and chief scientific officer, effective March 16, 2017. He succeeds Dr. Francis Cuss, 62, who will retire from the company. Dr. Cuss will serve as an advisor to the company for the next three months to ensure a seamless transition.

*Massachusetts General Hospital.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News